๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatic Steatosis in Hepatitis C: Comparison of Diabetic and Nondiabetic Patients in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial

โœ Scribed by Lok, Anna S.F.; Everhart, James E.; Chung, Raymond T.; Padmanabhan, Latha; Greenson, Joel K.; Shiffman, Mitchell L.; Everson, Gregory T.; Lindsay, Karen L.; Bonkovsky, Herbert L.; Di Bisceglie, Adrian M.


Book ID
122834025
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
222 KB
Volume
5
Category
Article
ISSN
1542-3565

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Evolution of hepatic steatosis in patien
โœ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 404 KB ๐Ÿ‘ 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo

Herbal product use by persons enrolled i
โœ Leonard B. Seeff; Teresa M. Curto; Gyongyi Szabo; Gregory T. Everson; Herbert L. ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 2 views

Herbal products, used for centuries in Far Eastern countries, are gaining popularity in western countries. Surveys indicate that persons with chronic hepatitis C (CHC) often use herbals, especially silymarin (milk thistle extract), hoping to improve the modest response to antiviral therapy and reduc

HCV RNA detection by TMA during the hepa
โœ Chihiro Morishima; Timothy R. Morgan; James E. Everhart; Elizabeth C. Wright; Mi ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 199 KB ๐Ÿ‘ 2 views

For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined. Prior interferon nonresponders with advanced fibrosis (n โ€ซุโ€ฌ 1,145) were retreated with peginterferon alpha-2a and ribavirin. Patients who were HCV RNA-negativ